Aclaris Therapeutics to Participate in the Leerink Partners 2026 Global Healthcare Conference Life Science Investing
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 Life Science Investing
Acadia Pharmaceuticals Announces Plan to Request Re-Examination Following Negative CHMP Opinion for Trofinetide for the Treatment of Rett Syndrome Life Science Investing
Tenaya Therapeutics to Participate in the Leerink Partners Global Healthcare Conference 2026 Life Science Investing
Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026 Life Science Investing
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer Life Science Investing
HCW Biologics Regains Compliance with All Continued Listing Rules for Nasdaq Per Nasdaq Determination Letter Life Science Investing
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales Life Science Investing
